Analysis of choroidal thickness in juvenile systemic lupus erythematosus and its correlation with laboratory tests

BMC Ophthalmol. 2023 Apr 11;23(1):148. doi: 10.1186/s12886-023-02906-4.

Abstract

Background: The aim of this study is to investigate the alterations of choroidal thickness (CT) in juvenile systemic lupus erythematosus (JSLE) using enhanced depth imaging optical coherence tomography (EDI-OCT). We also aimed to assess whether CT parameters correlated with systemic health status in JSLE patients.

Methods: JSLE patients and age- and sex-matched healthy subjects were recruited. A detailed ophthalmological examination was applied to all participants. CT measurements were acquired in the macular region using EDI-OCT. Moreover, a spectrum of laboratory tests was examined to evaluate the systemic conditions, and the Th1/Th2/Th17/Treg cytokine profiles in the peripheral blood were also analyzed in JSLE group.

Results: A total of 45 JSLE patients with no visual impairment and 50 healthy individuals were enrolled in the study. CT values in the macular region were decreased in JSLE patients when compared with healthy controls, even adjusting for age, axial length and refraction. There were no significant correlations between CT and cumulative dose of hydroxychloroquine or duration of hydroxychloroquine use (all P > 0.05). The average macular, temporal and subfoveal CT in JSLE group was negatively correlated with IL-6 and IL-10 (all P < 0.05), but had no significant correlations with other laboratory results (all P > 0.05).

Conclusions: JSLE patients without ocular involvement may have significant variations in choroidal thickness at the macular area. Choroidal alterations might be associated with the systemic cytokine profiles in JSLE.

Keywords: Choroidal thickness; Cytokine; Optical coherence tomography; Systemic lupus erythematosus.

MeSH terms

  • Choroid
  • Humans
  • Hydroxychloroquine*
  • Lupus Erythematosus, Systemic* / complications
  • Refraction, Ocular
  • Tomography, Optical Coherence

Substances

  • Hydroxychloroquine